PMID: 9630799Jun 19, 1998Paper

Transplantation of islets of Langerhans in type 1 diabetes. Three cases treated in Sweden to date

Läkartidningen
A Tibell, C G Groth

Abstract

The article consists in a report of the first three cases of human islet transplantation to have been carried out in Sweden. Cadaveric pancreatic glands were harvested and flown to the islet transplantation laboratory at the University of Giessen in Germany. After isolation, the islets were returned to Huddinge Hospital in Stockholm. The recipients were diabetic renal transplant patients, who received 5,000-8,000 islets by intraportal injection. Initially blood glucose levels were stabilised and HbA1c levels normalised, but no patient became insulin independent. After a few months serum C-peptide levels diminished, and after 6-10 months were undetectable. Islet function loss is probably to be explained by rejection and cytomegalvirus infection. In future cases new improved immunosuppressive protocols will be implemented.

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

Annals of the Royal College of Surgeons of England
N J London
European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes
C HenrikssonG Claes
© 2022 Meta ULC. All rights reserved